Mueller, Dirk <br/><br/>
Cost-effectiveness of using clinical risk factors with and without DXA for osteoporosis screening in postmenopausal women.  [electronic resource] 

 -  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research   
 - 1106-17 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1524-4733 
<br/><br/><label>Standard No.: </label>10.1111/j.1524-4733.2009.00577.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Absorptiometry, Photon--economics<br/>Aged<br/>Aged, 80 and over<br/>Alendronate--economics<br/>Bone Density<br/>Bone Density Conservation Agents--economics<br/>Cohort Studies<br/>Cost-Benefit Analysis<br/>Female<br/>Fractures, Bone--economics<br/>Germany--epidemiology<br/>Humans<br/>Markov Chains<br/>Mass Screening--economics<br/>Middle Aged<br/>Models, Economic<br/>Osteoporosis, Postmenopausal--complications<br/>Postmenopause<br/>Quality-Adjusted Life Years<br/>Risk Assessment<br/>Risk Factors<br/>Sensitivity and Specificity<br/>Women's Health